Semi-Annual Consolidated Statement Of Cash Flows

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7711657

Concept As at
2019-02-28
2018-03-01 to
2019-02-28
As at
2018-02-28
2017-03-01 to
2018-02-28
As at
2017-02-28
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
23,665,000,000 JPY
36,180,000,000 JPY
Interest and dividends received
1,465,000,000 JPY
1,240,000,000 JPY
Interest paid
-19,000,000 JPY
-32,000,000 JPY
Income taxes paid
-9,339,000,000 JPY
-6,935,000,000 JPY
Net cash provided by (used in) operating activities
15,772,000,000 JPY
30,453,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-3,626,000,000 JPY
-3,131,000,000 JPY
Proceeds from sale of property, plant and equipment
291,000,000 JPY
82,000,000 JPY
Purchase of investment securities
-353,000,000 JPY
-691,000,000 JPY
Proceeds from collection of loans receivable
6,000,000 JPY
6,000,000 JPY
Net cash provided by (used in) investing activities
-39,302,000,000 JPY
-1,378,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-71,000,000 JPY
-71,000,000 JPY
Purchase of treasury shares
-6,176,000,000 JPY
-2,000,000 JPY
Dividends paid
-6,882,000,000 JPY
-6,855,000,000 JPY
Net cash provided by (used in) financing activities
-13,347,000,000 JPY
-7,153,000,000 JPY
Dividends paid to non-controlling interests
-68,000,000 JPY
-59,000,000 JPY
Other, net
-48,000,000 JPY
-64,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-908,000,000 JPY
-963,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-37,786,000,000 JPY
20,959,000,000 JPY
Cash and cash equivalents
88,782,000,000 JPY
126,569,000,000 JPY
105,610,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.